(Q45409042)

14 December 2017

title

Sensitivity of hepatitis B virus DNA transcription-mediated amplification testing in hepatitis B surface antigen-positive blood donations (English)

1 reference

14 December 2017

0 references

1 reference

Françoise Bouchardeau

1

1 reference

14 December 2017

Annie Girault

2

1 reference

14 December 2017

Annie Razer

3

1 reference

14 December 2017

Annabelle Servant-Delmas

4

1 reference

14 December 2017

Mélanie Mercier

5

1 reference

14 December 2017

Syria Laperche

6

1 reference

14 December 2017

publication date

1 December 2006

1 reference

14 December 2017

1 reference

14 December 2017

volume

46

1 reference

14 December 2017

issue

12

1 reference

14 December 2017

page(s)

2047-2052

1 reference

International application of the incidence rate/window period model.

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.01031.X

High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.01031.X

Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993-2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.01031.X

Assessing the accuracy of three viral risk models in predicting the outcome of implementing HIV and HCV NAT donor screening in Australia and the implications for future HBV NAT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.01031.X

Estimated risk of transfusion-transmitted viral infections in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.01031.X

Analysis of HBV infection after blood transfusion in Japan through investigation of a comprehensive donor specimen repository

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.01031.X

Detection of an acute asymptomatic HBsAg negative hepatitis B virus infection in a blood donor by HBV DNA testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.01031.X

Superiority of minipool nucleic acid amplification technology for hepatitis B virus over chemiluminescence immunoassay for hepatitis B surface antigen screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.01031.X

Occult hepatitis B virus infection: implications in transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.01031.X

Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.01031.X

Hepatitis B virus infection--natural history and clinical consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.01031.X

Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window-phase donations not detected by NAT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.01031.X

Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.01031.X

Frequency and load of hepatitis B virus DNA in first-time blood donors with antibodies to hepatitis B core antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.01031.X

Determination of hepatitis B virus subtypes by an enzyme immunoassay method using monoclonal antibodies to type-specific epitopes of HBsAg

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.01031.X

Rapid and sensitive assays for determination of hepatitis B virus (HBV) genotypes and detection of HBV precore and core promoter variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.01031.X

Highly sensitive multiplex assay for detection of human immunodeficiency virus type 1 and hepatitis C virus RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.01031.X

Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.01031.X

The risk of hepatitis B virus infection by transfusion in Kumasi, Ghana

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.01031.X

Sensitive and accurate quantitation of hepatitis B virus DNA using a kinetic fluorescence detection system (TaqMan PCR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.01031.X

Lack of correlation between hepatitis B surface antigen and hepatitis B virus DNA levels in blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.01031.X

Identification of different states of hepatitis B virus infection with a quantitative PCR assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.01031.X

Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.01031.X

Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.01031.X

Infectivity of blood from PCR-positive, HBsAg-negative, anti-HBs-positive cases of resolved hepatitis B infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.01031.X

Low-level viraemia of hepatitis B virus in an anti-HBc- and anti-HBs-positive blood donor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.01031.X

Transfusion-transmitted HBV infection in an endemic area: the necessity of more sensitive screening for HBV carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.01031.X

An estimate of the current risk of transmitting blood-borne infections through blood transfusion in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.01031.X

10.1111/J.1537-2995.2006.01031.X

21 January 2018

Identifiers

DOI

1 reference

14 December 2017

1 reference